Drug factory · FDA FEI 3013030741

Primera Analytical Solutions Corporation

259 Prospect Plains Rd Bldg E-1 & E-2, Cranbury, NJ, United States

United States: 1

Problems found, fixed voluntarily at FDA's last inspection, Apr 12, 2024.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

3 drug inspections on record since 2018: 0 with no problems, 3 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
Lunsotogene ParvecTests it Regeneron Pharmaceuticals, Inc. 61755-062

FDA inspection history

EndedResultProgramProblems noted
Apr 12, 2024Problems found, fixed voluntarilyDrug Quality Assurance—
Oct 28, 2022Problems found, fixed voluntarilyBioresearch Monitoring—
May 18, 2018Problems found, fixed voluntarilyDrug Quality Assurance—

Registered with FDA for: analysis.